Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
2 studies found for:    10334533 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy
Condition: Breast Cancer
Intervention: Drug: Anastrozole
2 Completed
Has Results 		Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasm
Interventions: Drug: Docetaxel - Dose A;   Drug: Anastrozole;   Drug: cyclophosphamide;   Drug: Docetaxel - Dose B;   Drug: Doxorubicin hydrochloride;   Drug: Tamoxifen Citrate;   Drug: Capecitabine - Dose B;   Drug: Capecitabine - Dose A
To Top

† Indicates status has not been verified in more than two years